Science & Technology Review
|
2021, 39(20): 110-115
• Exclusive: Alzheimer's disease •
Evidence-based prevention guideline of Alzheimer's disease
Full
ZHANG Yaru, YU Jintai
Affiliations
Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
Published: 2021-10-28
doi: 10.3981/j.issn.1000-7857.2021.20.010
Outline
Recently, our paper entitled "evidense-based prevention of Alzheimer's disease" published in Journal of Neurology, Neurosurgery & Psychiatry (JNNP) has attached much attention. In this review, we will discuss the contents of this paper including the prevention strategies, the population difference, the current status and the future prospect of the AD, to guide the clinical practice of the AD primary prevention, such as the healthy lifestyles (the weight control, the physical exercise, the cognitive activity, sufficient and good quality sleep, and staying away from smoking), and the management of comorbidities (the diabetes, the high blood pressure, the hyperhomocysteinaemia, the cardiovascular disorders, the head trauma, and the depression), and it is shown that the high education and the vitamin C intake can reduce the incidence risk of the Alzheimer's disease (AD).
Alzheimer's disease
/
evidense-based prevention
/
international guideline
/
dementia
/
disease prevention
ZHANG Yaru, YU Jintai.
Evidence-based prevention guideline of Alzheimer's disease[J].
Science & Technology Review,
2021
, 39
(20)
: 110
-115
.
DOI: 10.3981/j.issn.1000-7857.2021.20.010
Year 2021 volume 39 Issue 20
PDF
1283
312
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2021.20.010
- Receive Date:2020-08-18
- Online Date:2021-11-08
- Published:2021-10-28